The UK is experiencing heightened pressure on its health system as hospitals report a significant rise in flu admissions, coinciding with industrial action by doctors. According to NHS England, the
All posts tagged in biotechnology
10Articles
Parkinson’s disease has long been considered intractable from a clinical and financial perspective. The debilitating tremors experienced by patients arise from a deficit of dopamine within the brain, often only
World leaders gathered in Beijing were momentarily caught off guard when Xi Jinping, Vladimir Putin and Kim Jongun were overheard discussing the future of human longevity and the potential for
A leading biopharmaceutical business saw its shares tumble by almost 40 per cent after results from a trial of its much-anticipated weight loss pill failed to meet market expectations. Viking
AstraZeneca, one of the world’s leading pharmaceutical companies, has announced a transformative acquisition of the Belgium-based biotech firm Esobiotec in a deal worth up to $1 billion. This strategic move
Australian biotechnology company BPH Global has unveiled groundbreaking research revealing significant concentrations of gold and copper in seaweed, opening new possibilities for sustainable metal extraction from seawater. Recent assays conducted
US technology mogul Larry Ellison has significantly increased his shareholding in Oxford Nanopore Technologies, emerging as one of the company’s most substantial investors through his Californian investment vehicle, EIT Oxford
Liverpool’s burgeoning life sciences sector is positioning itself as one of Europe’s premier biotech clusters, with projections indicating up to £800 million in investment over the next decade. The region’s
The pharmaceutical industry stands on the cusp of a major transformation as revolutionary weight-loss injections demonstrate potential far beyond their initial scope. Semaglutide, marketed under brands like Ozempic and Wegovy,
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), a stem cell-derived exosome-based drug delivery platform developer, is currently seeking new investors to enable the company to trade as a going concern following its
